Perhaps unexpectedly, PTK7 protein expression was not associated with the survival of specific receptor status subgroups, although PTK7 mRNA expression and the survival of patients with ER-positive, PgR-negative, and HER2-negative tumours were associated. This evidence concerns the gene ERBB2 and neoplasm.